Cognition Disorders

43 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Cognition Disorders
Treatment and conditionWhere it standsTrials
AB-1001 Gene Therapy for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Active tDCS with Sternberg task for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Aducanumab for cognitive dysfunctionTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
ATTN201 Focused Ultrasound to the CMN for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Audiovisual stimulation VR system for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Buntanetap tartrate for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cal-Mag Butyrate for cognition disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphovenous Anastomosis + Routine Treatment for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Device-only fitting for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Facilitate tDCS + CR for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fasudil for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Focused Transcranial Ultrasound for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GENUS device (Active Settings) for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ginkgo for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High doses of Thiamine y Biotin for huntington diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
human Mesenchymal Stem Cells for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
intra-striatal rAAV5-miHTT for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lecanemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
LY-2599666 for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mad for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Metformin hydrochloride for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Moderate doses of Thiamine y Biotin for huntington diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nicotinamide Riboside (NR) for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + ADUCANUMAB for cognitive dysfunctionTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + SRP-1005 for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Receive tDCS+CR for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
REPAIR Sleep for cognition disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RP902 for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sense4Safety for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Service-only Fitting for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 600mg for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 900mg for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Solanezumab for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Task-oriented resistance exercise for cognitive dysfunctionPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tominersen for huntington diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
tributyrin for cognitive dysfunctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Trontinemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Valacyclovir for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vericiguat for cognitive dysfunctionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Votoplam (blinded) for huntington diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1